An acne vaccination can prevent potential adverse effects of topical or systemic retinoids and antibiotics treatment options. This new vaccine includes bacterial strain instead of pathogens. The researchers from London demonstrated that antibodies from a toxin, secreted by bacteria in acne vulgaris can reduce inflammation in acne lesions. Instead of invading pathogens, the new vaccine firstly targets the bacteria which is already present in the human skin.
Once this vaccine is validated by a large-scale clinical trial, the potential impact of this findings helps the millions of individuals suffering from acne vulgaris. This vaccination can avoid the potential adverse effects of topical or systemic retinoids and antibiotics. In the Study, they found that Christie-Atkins-Munch-Peterson (CAMP) factor - a toxin secreted from the Propionibacterium acnes (P. acnes) bacteria, which can induce…
